Updates in Lymphoma [2023] Interview – Elizabeth Brem, MD – MOASC Lymphoma 2 Mins Read14 Elizabeth Brem , MD discusses the design and outcomes of the study referred to as 1826. The study aimed to…
Brentuximab v. Nivolumab cHL SWOG S1826 [Slides] Brem, MD – MOASC Non-Hodgkin Lymphoma 4 Mins Read11 Updates in Lymphoma: Advancements in Treatment Strategies Date: August 12, 2023Presenter: Elizabeth Brem, MD (Clinical Associate Professor) In the ever-evolving…
Brentuximab: ASH 2022 Dr. Mitul Gandhi Updated Efficacy and Safety Results Hodgkin Lymphoma 9 Mins Read2 iFrame is not supported! Brentuximab: ASH 2022 Dr. Mitul Gandhi Updated Efficacy and Safety Results By Mitul Gandhi, MD What…
